CYSTIC FIBROSIS FOUNDATION enters ARIDIS PHARMACEUTICALS, INC. with 5.17M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 12/19/2022ACC: 0000899243-22-038926
10% Owner
Since Dec 2022
5.17M
Baseline shares
100% direct
5.17M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.0001 per share
DirectShares owned5.17M
Total
5.17M direct5.17M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.0001 per share | 5.17M | Direct |
| Total | 5.17M | 5.17M direct |
Derivative Holdings0
No derivative holdings reported